Log In
Discover
Assets
Jobs
Behance
Pro
Hire Freelancers
Download on the App Store
Get it on Google Play
English
Čeština
Dansk
Deutsch
Español
Français
Italiano
Nederlands
Norsk
Polski
Português
Pусский
Suomi
Svenska
Türkçe
日本語
한국어
中文(简体)
中文(繁體)
About
Blog
TOU
Privacy
Community
Help
Do not sell or share my personal information
Sign Up
Skip to Main Content
Skip to Footer
Behance
Behance
Navigate to behance.net
Explore
Assets
Jobs
Behance
Pro
Hire Freelancers
search
magnifying glass
Sort & filter all:
Projects
Images
People
Assets
People to Hire
Cancel
search
magnifying glass
View your notifications within Behance.
View your notifications within Behance.
Log In
Sign Up
search
magnifying glass
Adobe, Inc.
Adobe, Inc.
Navigate to adobe.com
Follow
Unfollow
Follow
Following
Message
Add to Moodboard
Save
Share & Embed This Project
Share
Appreciate
Appreciate
Follow
Following
Unfollow
Follow
Unfollow
Self Defense For Organs
M.Youssef El Naggar
•
Follow
Following
Unfollow
Agency:
McCANN Health Dubai
Client:
Merck Serono
Brand:
Glucovance
--
Executive Creative Director:
Mark Shadwell
Sr. Art Director:
Mohamed Youssed El Naggar (Joe El Naggar)
Copywriter:
Mark Shadwell
CGI:
Gravy
Join Behance
Sign up
or
Sign in
to view personalized recommendations, follow creatives, and more.
Sign Up With Email
Sign Up
or
Join Behance
Sign up
or
Sign in
to view personalized recommendations, follow creatives, and more.
Sign Up With Email
Sign Up
or
Self Defense For Organs
191
2.4k
11
Published:
September 19th 2016
M.Youssef El Naggar
Follow
Following
Unfollow
Owner
M.Youssef El Naggar
Dubai, United Arab Emirates
Follow
Following
Unfollow
Message
Credits
Gravy
Follow
Following
Unfollow
Self Defense For Organs
The most common long-term effects of diabetes are damage to the body’s major organs. Glucovance is unique – not only does it effectively treat di
Read More
191
2.4k
11
Published:
September 19th 2016
Creative Fields
Art Direction
Advertising
Creative Direction
organs
self-defense
diabetes
medicine
protection
Copyright Info
Attribution, Non-commercial, No Derivatives
Read More
Report